A phase 3 randomized double blind study of PF 06439535 plus paclitaxel carboplatin and bevacizumab plus paclitaxel carboplatin for the first line treatment of patients with advanced non squamous non small cell lung cancer
Supported projects > Other Supported Projects · 2016
Authors: Tuncay GÖKSEL
2016-2019, Other Supported Projects, R & D Project, Completed